Abiopharma

DAVIS A BRIAN 🟢 acquired 10.0K shares (1 derivative) of Grace Therapeutics, Inc. (GRCE) at $3.80 Transaction Date: Jan 08, 2026 | Filing ID: 000966

(90% Positive) Atara Biotherapeutics Inc (ATRA) Announces Clinical Development Update

Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™

Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners

📋 Gut Robert (Director) plans to sell 26K shares of uniQure N.V. (at $26.42 each, total $677K) Filed: Jan 12, 2026 | ID: 000009

Best Frame TV: Top Picks for Your Home in 2026

Best Free Reverse Phone Lookup Services for 2026

(70% Positive) 10X Genomics Inc (TXG) Reports Q1 2026 Financial Results

New Form 424B3 - Mitesco, Inc. Filed: 2026-01-12 AccNo: 0001185185-26-000110 Size: 1 MB

La Francia espande laccesso nazionale allAAC per botensilimab + balstilimab di Agenus per il carcinoma ovarico e i sarcomi dei tessuti molli

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 8-K/A - Jaguar Health, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010173 Size: 515 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: …

📋 Myles David C. (Officer) plans to sell 10K shares of Olema Pharmaceuticals, Inc. (at $28.34 each, total $283K) Filed: Jan 12, 2026 | ID: 000257

New Form D - CYBIN INC. Filed: 2026-01-12 AccNo: 0000912282-26-000021 Size: 12 KB

New Form 8-K/A - BIODESIX INC Filed: 2026-01-12 AccNo: 0001193125-26-010114 Size: 200 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits